Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-03-09, Stock:ABT, The news for the past five days is as follows:
2021-03-02: NEWS1: Abbott Announces HIV Vaccine Research Findings: 'Another Step Toward Unlocking A Cure'.NEWS2: Abbott says researchers in the Democratic Republic of Congo have made findings that could lead to HIV vaccine.NEWS3: Abbott Researchers Find Rare Group of People With Controlled HIV Who Could Be a Key To Unlocking Cure.NEWS4: Top Healthcare Stocks to Buy for 2021.
2021-03-03: NEWS1: Veeva Systems (VEEV) Q4 Earnings and Revenues Beat Estimates.NEWS2: Patterson Companies (PDCO) Q3 Earnings Top Estimates, Up Y/Y.NEWS3: Abbott Receives Health Canada Authorization Under Interim Order to Expand Use of FreeStyle® Libre System for Pregnant Women in the Hospital and Professional Health Care Settings.
2021-03-04: NEWS1: National Vision (EYE) Q4 Earnings Top Estimates, Margins Up.NEWS2: Masimo's (MASI) Rad-G with Temperature Receives CE Marking.NEWS3: Abbott (ABT) Gets Canadian Nod for FreeStyle Libre Expanded Use.
2021-03-05: NEWS1: Abbott (ABT) Gains But Lags Market: What You Should Know.NEWS2: Abbott's Molecular Assay Gets FDA EUA Approval To Detect SARS-CoV-2 And Flu In One Test.NEWS3: UPDATE 1-Abbott's test to distinguish coronavirus and flu viruses gets U.S. authorization.NEWS4: Cooper Companies (COO) Q1 Earnings & Revenues Top Estimates.NEWS5: Abbott Receives FDA EUA for Laboratory PCR Assay That Detects and Differentiates SARS-CoV-2, Flu A, Flu B and RSV in One Test - and FDA EUA for Asymptomatic Usage of Alinity m COVID-19 Test.
2021-03-08: NEWS1: What Does Abbott's Debt Look Like?.NEWS2: Abbott Introduces NeuroSphere™ Virtual Clinic, First-of-its-Kind Remote Neuromodulation Patient-Care Technology in the U.S..NEWS3: The Zacks Analyst Blog Highlights: Abbott, Johnson & Johnson, Masimo Corp and Medtronic.NEWS4: Abbott’s Alinity m Resp-4-Plex Test Cleared For Emergency Use In US; Street Says Buy.

Answer: Rise